Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brainsway (BWAY) Cash & Equivalents (2018 - 2026)

Brainsway has reported Cash & Equivalents over the past 9 years, most recently at $67.7 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 2.37% year-over-year to $67.7 million; the TTM value through Mar 2026 reached $67.7 million, down 2.37%, while the annual FY2025 figure was $67.7 million, 2.37% down from the prior year.
  • Cash & Equivalents was $67.7 million for Q1 2026 at Brainsway, roughly flat from $67.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $69.3 million in Q4 2024 and bottomed at $10.5 million in Q4 2023.
  • The 5-year median for Cash & Equivalents is $67.7 million (2025), against an average of $55.4 million.
  • Year-over-year, Cash & Equivalents tumbled 77.89% in 2023 and then surged 559.17% in 2024.
  • Over 5 years, Cash & Equivalents stood at $47.6 million in 2022, then tumbled by 77.89% to $10.5 million in 2023, then surged by 559.17% to $69.3 million in 2024, then dropped by 2.37% to $67.7 million in 2025, then changed by 0.0% to $67.7 million in 2026.
  • The last three reported values for Cash & Equivalents were $67.7 million (Q1 2026), $67.7 million (Q4 2025), and $69.3 million (Q1 2025) per Business Quant data.